Supply Disruption Alert: Tocilizumab (RoActemra®) 162mg/0.9ml solution for injection pre-filled syringes and pre-filled pens – Non COVID-19 indications
[This alert was updated on 23/12/2021 - See link below] These products are in limited supply until January 2022. Prescribers should urgently review their Rheumatoid Arthritis guidelines and amend in line with the advice in the clinical prioritisation section of the Supply Disruption Alert.
Published